Back

Impact of established cardiovascular disease on outcomes in the Global Leaders trial

3 September 2019 (11:27 - 11:36)
Organised by:
Congress Presentation Part of: Coronary artery disease - Epidermiology, prognosis and outcome Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Scot Garg

Royal Blackburn Hospital, Blackburn (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Recurrent coronary heart disease in the year following myocardial infarction among US men and women between 2008 and 2015
Doctor S. Peters (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels - A RAPID CPU substudy
Doctor M. Biener (Schwetzingen, DE)
Abstract Slides Video
Presentation thumbnail
Percutaneous coronary intervention provided better result than optimal medical therapy in patients with chronic total occlusion: a metanalysis
Doctor D. Khanra (CHESTER, GB)
Abstract Slides Video
Presentation thumbnail
Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study
Doctor T. Unoki (Kumamoto, JP)
Abstract
Presentation thumbnail
Coronary artery calcification predicts MACE and all-cause mortality in individuals undergoing non-cardiac computed tomography for non-cardiovascular indications
Doctor D. Banerji (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary artery disease - Epidermiology, prognosis and outcome

The Event

Event poster

ESC Congress 2019

3 September 2019 11:27 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources